Talk Bio

Actionable Insights Powered by AI

Subscribe

FGFR3 protein, human

Tyra Biosciences Unveils Early Data for FGFR3 Inhibitor, TYRA-300, in Challenge to J&J’s Balversa

talkbio0Tagged , , , , , , , , , ,

Tyra Biosciences, TYRA-300, Balversa, J&J, bladder cancer, urothelial carcinoma, FGFR3 inhibitor, safety concerns, efficacy data

Read More